Microchip Technology (MCHP) has just posted Q3 2026 results with revenue of US$1,186 million, Basic EPS of US$0.06 and net income of US$34.9 million, giving investors a cleaner snapshot after a period of mixed quarterly earnings. The company has seen revenue move from US$970.5 million in Q4 2025 to US$1,186 million in Q3 2026, while Basic EPS has ranged from a loss of US$0.29 in Q4 2025 to a profit of US$0.06 in the latest quarter. This sets the stage for investors to focus squarely on how stable these margins really are.

See our full analysis for Microchip Technology.

With the latest numbers on the table, the next step is to see how this earnings profile lines up with the key narratives around growth, profitability and risk that are guiding expectations.

Four-quarter swing from losses to profit

• On a trailing 12 month basis, Microchip reported a net loss of US$154.4 million and Basic EPS of a US$0.29 loss, even though the latest single quarter shows a profit of US$34.9 million and Basic EPS of US$0.06.
• Bulls point to efficiency plans and higher-margin products as the backbone of a profit recovery, but the recent history of losses keeps the bar high.
  • The bullish narrative expects margins to reach 25.6% and earnings of about US$2.1b by around 2028, compared with the recent trailing loss of US$154.4 million.
  • That view leans heavily on cost savings and inventory clean up, while the trailing EPS loss of US$0.29 over the last year shows the turnaround is still being earned and is not yet reflected in longer term numbers.

Bulls arguing that Q3 is the start of a durable earnings reset will want to see how this quarter stacks up against the detailed assumptions in the 🐂 Microchip Technology Bull Case

Revenue near US$1.2b, but TTM still soft

• Quarterly revenue has moved from US$970.5 million in Q4 2025 to US$1,186 million in Q3 2026, while trailing 12 month revenue sits at US$4.4b, below the earlier trailing figures of US$4.8b and US$5.5b shown for 2025.
• Consensus narrative talks about broad-based end market recovery, yet the trailing revenue trend highlights that a lot of the recent story is still about coming off a higher base.
  • Analysts in the consensus view model revenue growth of about 18.5% a year to roughly US$7.3b by 2029, compared with the latest trailing US$4.4b figure.
  • With trailing net income at a loss of US$154.4 million, the idea of sustained growth plus a return to roughly US$1.9b of earnings asks current results to catch up to expectations that are described as fairly ambitious.

Rich P/S versus losses and cash coverage risks

• The stock trades at US$101.58 with a P/S of 12.6x, above the US semiconductor industry at 8.7x, while the cited DCF fair value is US$61.12 and trailing 12 month net income is a loss of US$154.4 million.
• Bears argue that paying a premium multiple while the company is loss making and has weak coverage of dividends and interest is a risky setup.
  • The dividend yield of 1.79% is flagged as not well covered by either earnings or free cash flow, and interest payments are not well covered by earnings based on the trailing numbers.
  • Set against a P/S above the industry and a DCF fair value of US$61.12, those financing pressures support the bearish concern that the current US$101.58 price already assumes a lot of future improvement.

If you are weighing whether the current premium price fairly reflects those risks, it is worth lining these results up with the detailed arguments in the 🐻 Microchip Technology Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Microchip Technology on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both bulls and bears presenting clear talking points, this is a moment to move quickly, review the underlying numbers yourself, and form an independent view using the 1 key reward and 3 important warning signs

See What Else Is Out There

Microchip Technology combines a trailing 12 month net loss of US$154.4 million with a premium 12.6x P/S and weak dividend and interest coverage.

If you are uneasy about paying up for a stock with uncovered payouts and financing strain, compare it with companies in the solid balance sheet and fundamentals stocks screener (44 results) to focus on sturdier balance sheets and fundamentals right now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.